-
Markets
-
Equities
Sustainable finance2025 Euronext ESG Trends ReportRead moreA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesRead moreThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETFs
The European market place for ETFsEuronext ETF EuropeRead moreInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Funds
-
Fixed Income
European Defence BondsGroupe BPCE lists the first bondRead moreFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Structured Products
-
Derivatives
Where European Government Bonds Meet the FutureFixed Income derivativesRead moreTrade mini bond futures on main European government bonds
-
Commodities
- Overview
- Quotes snapshot
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Delivery & settlement
- Specifications & arrangements
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesRead moreEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Resources
Designed to help students navigate the complexities of financial marketsEuronext Trading gameRead moreJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
ORAGENICS
Identification
Listing sponsor / Agent
BRYAN, GARNIER AND CO Ltd
Symbol
ALONI
ISIN code
US6840231046
Exchange / Market
Euronext Growth
Trading location
Paris
ICB
Biotechnology
Website address
http://www.onibiopharma.com
Issuer website
http://www.onibiopharma.com
Operation
IPO date
Mon 15/12/2008
IPO type
Cotation directe
IPO type
Initial Public offering
Catégorie
IPO
Operation procedure
- Nombre de titres à admettre : 38 318 478 - Cours de référence : cours de clotûre de l'action Oragenics du 12/12/2008 sur NYSE Alternext US, converti en EUR selon le taux de change du 12/12/2008.
Operation description
Admission sur Alternext des 38 318 478 actions ordinaires composant le capital de la société
ORAGENICS. La société ORAGENICS, dont le nom commercial est ONI BioPharma, est par ailleurs cotée sur NYSE Alternext US.
Operation calendar
15 décembre 2008 : admission aux négociations des actions émises par ORAGENICS